Home Cart Sign in  
Chemical Structure| 115436-72-1 Chemical Structure| 115436-72-1

Structure of Risedronic acid sodium
CAS No.: 115436-72-1

Chemical Structure| 115436-72-1

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Risedronate sodium is a pyridinyl biphosphonate which inhibits osteoclast-mediated bone resorption.

Synonyms: Risedronate sodium; Risedronate (sodium salt)

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Risedronic acid sodium

CAS No. :115436-72-1
Formula : C7H10NNaO7P2
M.W : 305.09
SMILES Code : OC(P(O)(O)=O)(P([O-])(O)=O)CC1=CC=CN=C1.[Na+]
Synonyms :
Risedronate sodium; Risedronate (sodium salt)
MDL No. :MFCD01706268

Safety of Risedronic acid sodium

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302+H312+H332
Precautionary Statements:P280

Isoform Comparison

Biological Activity

Description
Risedronic acid sodium, a pyridinyl biphosphonate, effectively inhibits osteoclast-mediated bone resorption. It has been shown to prevent bone loss or enhance bone density in both men and women undergoing long-term corticosteroid therapy[1].

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT02155595 - Active, not recruiting August 2018 United States, Michigan ... More >> Henry Ford Medical Center, New Center One Detroit, Michigan, United States, 48202 Less <<
NCT02598453 Postmenopausal Osteoporosis Phase 4 Completed - -
NCT00545779 Post-Menopausal Osteoporosis Phase 3 Completed - Albania ... More >> Tirana, Albania Bosnia and Herzegovina Banja Luka, Bosnia and Herzegovina, 78000 Sarajevo, Bosnia and Herzegovina, 71 000 Sarajevo, Bosnia and Herzegovina, 71000 Tuzla, Bosnia and Herzegovina, 75000 Croatia Rijeka, Croatia, 51000 Slavonski Brod, Croatia, 35000 Split, Croatia, 21000 Zagreb, Croatia, 10000 Macedonia, The Former Yugoslav Republic of Skopje, Macedonia, The Former Yugoslav Republic of Serbia Belgrade, Serbia, 11000 Niska Banja, Serbia, 18205 Novi Sad, Serbia, 21000 Turkey Adana, Turkey, 01330 Ankara, Turkey, 06100 Ankara, Turkey, 06550 Antalya, Turkey, 07070 Aydin, Turkey, 09100 Bursa, Turkey, 16059 Denizli, Turkey, 20020 Erzurum, Turkey, 25240 Gaziantep, Turkey, 27310 Istanbul, Turkey, 34300 Istanbul, Turkey, 34303 Istanbul, Turkey, 35340 Istanbul, Turkey, 81190 Izmir, Turkey, 35100 Kayseri, Turkey, 38039 Konya, Turkey, 42080 Manisa, Turkey, 45200 Samsun, Turkey, 55139 Trabzon, Turkey, 61080 Less <<
NCT01907269 - Completed - -
NCT00545779 - Completed - -
NCT00809484 - Completed - Greece ... More >> Hellenic Breast Surgeons Society Athens, Greece, 11527 Less <<
NCT01907269 Osteoporosis Not Applicable Completed - United States, Alabama ... More >> University of Alabama at Birmingham Birmingham, Alabama, United States, 35205 United States, California Cedars-Sinai Medical Center Los Angeles, California, United States, 90048 United States, Massachusetts University of Massachusetts at Worcester Worcester, Massachusetts, United States, 01655 United States, New York New York University New York, New York, United States, 10016 United States, Ohio Jewish Hospital of Cincinnati Cincinnati, Ohio, United States, 45236 United States, Pennsylvania University of Pittsburgh Pittsburgh, Pennsylvania, United States, 15213 United States, Washington Group Health Research Institute Seattle, Washington, United States, 98101 Less <<
NCT02604836 Postmenopausal Osteoporosis Phase 4 Completed - -
NCT00136058 Osteoporosis Phase 3 Completed - Canada, Alberta ... More >> University of Alberta Edmonton, Alberta, Canada, T6G2S2 Less <<
NCT01077817 - Completed - -
NCT01077817 - Completed - -
NCT01882400 Osteoporosis ... More >>Muscular Dystrophy Cystic Fibrosis Less << Phase 4 Completed - Canada, Quebec ... More >> Centre hospitalier universitaire de Sherbrooke Sherbrooke, Quebec, Canada, J1H 5N4 Less <<
NCT01038011 Ankylosing Spondylitis Phase 2 Completed - Switzerland ... More >> Zurich, Switzerland Less <<
NCT00447915 Primary Osteoporosis Phase 3 Completed - Japan ... More >> Chubu/Kansai region Chubu/Kansai, Japan Chugoku/Kyusyu region Chugoku/Kyusyu, Japan Hokkaido/Tohoku region Hokkaido/Tohoku, Japan Kanto/Koshinetsu region Kanto/Koshinetsu, Japan Less <<
NCT00145704 - Terminated(due to low enrollme... More >>nt, participants are no longer being examined or treated) Less << - -
NCT00145704 Osteopenia Not Applicable Terminated(due to low enrollme... More >>nt, participants are no longer being examined or treated) Less << - United States, New York ... More >> Upstate Medical University Syracuse, New York, United States, 13210 Less <<
NCT01406613 - Unknown August 2014 United Kingdom ... More >> Sheffield Teaching Hospitals NHS Foundation Trust Sheffield, South Yorks, United Kingdom, S5 7AU Less <<
NCT01950169 Hip Fracture Not Applicable Completed - Sweden ... More >> Department of Geriatric Medicine R94, Karolinska University Hospital Stockholm, Sweden, SE-141 86 Less <<
NCT00089843 Anorexia Nervosa Phase 2 Phase 3 Completed - United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Less <<
NCT00887354 Osteoporosis Phase 4 Completed - -
NCT00089843 - Completed - -
NCT00092040 Osteoporosis, Postmenopausal Phase 3 Completed - -
NCT00869622 Epilepsy Bone... More >> Loss Osteoporosis Fractures Less << Phase 4 Completed - United States, Massachusetts ... More >> VA Boston Healthcare System Boston, Massachusetts, United States, 02130 Less <<
NCT00869622 - Completed - -
NCT01806792 Postmenopausal Women Osteoporo... More >>sis Less << Phase 3 Completed - Korea, Republic of ... More >> Chung-ang university hospital Seoul, Korea, Republic of, 156-755 Less <<
NCT00887354 - Completed - -
NCT00365456 Osteoporosis Phase 3 Completed - Denmark ... More >> Roskilde, Denmark Less <<
NCT01709110 - Completed - -
NCT00918749 Postmenopausal Osteoporosis Phase 2 Completed - United States, Florida ... More >> Research Site Daytona, Florida, United States, 32117 Research Site Ft. Myers, Florida, United States, 33901 United States, Hawaii Research Site Honolulu, Hawaii, United States, 96821 United States, Indiana Research Site Evansville, Indiana, United States, 47711 United States, Texas Research Site Austin, Texas, United States, 78727 Research Site Dallas, Texas, United States, 75247 Less <<
NCT00365456 - Completed - -
NCT01406444 Anorexia Nervosa ... More >> Osteopenia Osteoporosis Less << Not Applicable Active, not recruiting March 2019 United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Less <<
NCT00485953 Bone Loss Ost... More >>eoporosis Breast Cancer Less << Phase 4 Completed - United States, Pennsylvania ... More >> University of Pittsburgh Medical Center Pittsburgh, Pennsylvania, United States, 15213 Less <<
NCT01709110 Postmenopausal Osteoporosis Phase 4 Completed - -
NCT00918749 - Completed - -
NCT00666627 Post-menopausal Osteoporosis Phase 2 Completed - United Kingdom ... More >> Academic Unit of Bone Metabolism (Sheffield) Sheffield, South Yorkshire, United Kingdom, S5 7AU Less <<
NCT00386360 Osteopenia Phase 3 Completed - Argentina ... More >> Research Facility Buenos Aires, Argentina, C1012AAR Australia, Victoria Research Facility Heidelberg, Victoria, Australia, 3081 Canada, Ontario Research Facility Toronto, Ontario, Canada, M5G 2C4 France Research Facility Lyon, France Research Facility Saint-Etienne, France Research Facility Toulouse, France Germany Research Facility Berlin, Germany Switzerland Research Facility Geneva, Switzerland United Kingdom Research Facility Cambridge, United Kingdom Less <<
NCT00485953 - Completed - -
NCT00324714 Breast Cancer ... More >> Osteoporosis Less << Phase 3 Withdrawn - Switzerland ... More >> Inselspital Bern Bern, Switzerland, CH-3010 Oncocare Sonnenhof-Klinik Engeriedspital Bern, Switzerland, CH-3012 Less <<
NCT00268632 Osteoporosis Phase 3 Completed - -
NCT00577395 Osteoporosis Phase 4 Terminated - United States, Arizona ... More >> Research Facility Tuscon, Arizona, United States, 85704 United States, Nebraska Research Facility Omaha, Nebraska, United States, 68729 United States, Ohio Research Site Cincinnati, Ohio, United States, 45201 Argentina Research Facility Buenos Aires, Argentina Less <<
NCT00244907 Osteoporosis ... More >>Osteopenia Less << Phase 1 Completed - United States, Indiana ... More >> Purdue University West Lafayette, Indiana, United States, 47907 Less <<
NCT00103740 Paget's Disease of Bone Phase 3 Completed - -
NCT00577395 - Terminated - -
NCT02148848 Osteoporotic Fractures ... More >> Femoral Neck Fracture Less << Phase 4 Unknown October 2017 Thailand ... More >> Siriraj Hospital Recruiting Bangkoknoi, Bangkok, Thailand, 10700 Principal Investigator: Aasis Unnanantana, M.D. Less <<
NCT00118508 Osteoporosis Not Applicable Completed - United States, Pennsylvania ... More >> University of Pittsburgh Medical Center (GCRC) Pittsburgh, Pennsylvania, United States, 15213 Less <<
NCT00503399 Osteoporosis Phase 3 Completed - Germany ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Bad Nauheim, Germany, 61231 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Frankfurt, Germany, 60528 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Hamburg, Germany, 22415 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Heinsberg, Germany, 52525 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Leverkusen, Germany, 51375 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Magdeburg, Germany, 39110 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Potsdam, Germany, 14469 Greece For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Kifissia, Greece, 14561 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Thessaloniki, Greece, 56429 Italy For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Rome, Italy, 00161 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Siena, Italy, 53100 Spain For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Barcelona, Spain, 08907 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Madrid, Spain, 28046 Less <<
NCT00043069 Osteoporosis ... More >>Prostate Cancer Less << Phase 3 Completed - -
NCT00092014 Postmenopausal Osteoporosis Phase 3 Completed - -
NCT00503399 - Completed - -
NCT00372372 Osteoporosis Phase 4 Completed - China ... More >> Tuen Mun Hospital Hong Kong, China Less <<
NCT00051636 Paget's Disease of Bone Phase 3 Completed - -
NCT00567606 Postmenopausal Osteoporosis Phase 4 Completed - United States, Nebraska ... More >> University of Nebraska Medical Center, College of Nursing Kearney, Nebraska, United States, 68849-4510 University of Nebraska Medical Center, College of Nursing Lincoln, Nebraska, United States, 68588-0220 University of Nebraska Medical Center, College of Nursing Omaha, Nebraska, United States, 68198-5330 University of Nebraska Medical Center, College of Nursing Scottsbluff, Nebraska, United States, 69361-4939 Less <<
NCT00051636 - Completed - -
NCT00266708 Renal Transplant Osteodystroph... More >>y Less << Not Applicable Completed - United States, New York ... More >> Montefiore Medical Center Bronx, New York, United States, 10467 Less <<
NCT00103740 - Completed - -
NCT00082277 Breast Cancer Phase 4 Completed - -
NCT00353080 Osteoporosis, Postmenopausal Phase 3 Completed - Finland ... More >> Sanofi-Aventis Helsinki, Finland Netherlands Sanofi-Aventis Gouda, Netherlands Norway Sanofi-Aventis Oslo, Norway Spain Sanofi-Aventis Madrid, Spain Sweden Sanofi-Aventis Stockholm, Sweden Less <<
NCT00859703 Breast Cancer ... More >> Menopause Osteopenia Less << Phase 3 Completed - France ... More >> Service de Rhumatology et de Pathologie Osseuse, Hôpital Edouard Herriot Lyon, France, 69437 Less <<
NCT01575873 Steroid-induced Osteopor, Gluc... More >>ocorticoid-induced Ostepor Less << Phase 3 Completed - -
NCT00386360 - Completed - -
NCT01575873 - Completed - -
NCT00138866 Osteoporosis Phase 3 Completed - Canada, Ontario ... More >> Toronto Rehab, Lyndhurst Centre Toronto, Ontario, Canada, M4G 3V9 Less <<
NCT00402441 Osteoporosis, Postmenopausal Phase 4 Completed - United States, New Jersey ... More >> Sanofi-Aventis Administrative Office Bridgewater, New Jersey, United States, 08807 Less <<
NCT00351091 OSTEOPOROSIS, POSTMENOPAUSAL Phase 2 Completed - -
NCT00358176 Osteoporosis Postmenopausal Phase 3 Completed - United States, New Jersey ... More >> Sanofi-Aventis Bridgewater, New Jersey, United States, 08807 Argentina Sanofi-Aventis San Isidro, Argentina Australia Sanofi-Aventis Macquarie Park, Australia Canada Sanofi-Aventis Laval, Canada Czech Republic Sanofi-Aventis Prague, Czech Republic France Sanofi-Aventis Paris, France Lebanon Sanofi-Aventis Beirut, Lebanon Poland Sanofi-Aventis Warszawa, Poland South Africa Sanofi-Aventis Midrand, South Africa Turkey Sanofi-Aventis Istanbul, Turkey United Kingdom Sanofi-Aventis Guildford Surrey, United Kingdom Less <<
NCT00577720 Postmenopausal Women Phase 2 Completed - United States, California ... More >> Research Facility Costa Mesa, California, United States, 92626 United States, Florida Research Facility Gainsville, Florida, United States, 32608 Research Facility Miami, Florida, United States, 33126 United States, Hawaii Research Facility Honolulu, Hawaii, United States, 86813 United States, Texas Research Site Dallas, Texas, United States, 75247 Research Facility San Antonio, Texas, United States, 78229 Less <<
NCT00445575 Fibrous Dysplasia of Bone Phase 2 Phase 3 Unknown July 2014 Belgium ... More >> Cliniques Universitaires Saint Luc Recruiting Brussels, Belgium, 1200 Contact: JEAN PIERRE DEVOGELAER, MD    3227645390    devogelaer@ruma.ucl.ac.be    France Hopital E Herriot Recruiting Lyon, France, 69437 Contact: ROLAND D CHAPURLAT, MD PhD    33472117481    roland.chapurlat@chu-lyon.fr    Hopital Lariboisiere Recruiting Paris, France, 75475 Contact: PHILIPPE ORCEL, MD PhD    33149958631    philippe.orcel@lrb.ap-hop.paris.fr    Hopital Cochin Recruiting Paris, France, 75679 Contact: CHRISTIAN ROUX, MD PhD    33158412584       Germany Hospital Benjamin Franklin Not yet recruiting Berlin, Germany, 12200 Contact: DIETER FELSENBERG, MD PhD    4930844530456    dieter.felsenberg@charite.de    Cologne Clinical Centre Not yet recruiting Cologne, Germany, 50924 Contact: Eckhard SCHÖNAU    +49 221 4785851 ext 4360    Eckhard.schoenau@uk-koeln.de    Heildeberg Clinical Centre Not yet recruiting Heidelberg, Germany, 69120 Contact: Christian KASPERK, MD PhD    +49 6221 56 86 05    Christian.kasperk@med.uni-heidelberg.de    Netherlands Leids Universitair Medisch Centrum Recruiting Leiden, Netherlands, 2300 Contact: Neveen HAMDY, MD PhD    31715269111    endocrinologie@lume.nl Less <<
NCT00150696 Acute Spinal Cord Injury. Phase 3 Completed - Canada, Ontario ... More >> Hamilton Health Sciences, Chedoke Site Hamilton, Ontario, Canada, L8N 3Z5 Toronto Rehab, Lyndhurst Centre Toronto, Ontario, Canada, M4G 3V9 Less <<
NCT00577720 - Completed - -
NCT00054418 Breast Cancer ... More >> Osteoporosis Less << Phase 3 Completed - -
NCT03411902 Bariatric Surgery Candidate ... More >> Bone Loss Weight Loss Less << Phase 4 Recruiting February 28, 2019 United States, North Carolina ... More >> Wake Forest University Recruiting Winston-Salem, North Carolina, United States, 27106 Contact: Kristen M Beavers, PhD    336-758-5855    beverkm@wfu.edu    Contact: Beverly A Nesbit, MA    336-758-4272    nesbitba@wfu.edu Less <<
NCT03208582 Osteogenesis Imperfecta Phase 2 Completed - United Kingdom ... More >> Clinical Research Facility Sheffield, South Yorkshire, United Kingdom, S10 2TH Less <<
NCT00544180 Osteoporosis Phase 4 Terminated(The trial was termi... More >>nated due to lack of compliance with GCP regulations.) Less << - Israel ... More >> Sanofi-Aventis Natanya, Israel Less <<
NCT00868907 Healthy Phase 1 Completed - United States, Florida ... More >> Research Site Gainesville, Florida, United States, 32601 Research Site Miami, Florida, United States, 33126 United States, Hawaii Research Site Honolulu, Hawaii, United States, 96821 United States, Indiana Research Site Evansville, Indiana, United States, 47711 Less <<
NCT01904110 Osteoporosis Phase 4 Completed - Korea, Republic of ... More >> Samsung Medical Center Seoul, Korea, Republic of Less <<
NCT00778154 - Completed - United States, California ... More >> Warner Chilcott Research Facility Palm Desert, California, United States, 92269 United States, Colorado Warner Chilcott Research Facility Lakewood, Colorado, United States, 80227 United States, Georgia Warner Chilcott Research Facility Decatur, Georgia, United States, 30033 Warner Chilcott Research Facility Gainesville, Georgia, United States, 30501 United States, Nebraska Warner Chilcott Research Facility Omaha, Nebraska, United States, 68131 United States, Ohio Warner Chilcott Research Facility Cincinnati, Ohio, United States, 45219 United States, Pennsylvania Warner Chilcott Research Facility Wyomissing, Pennsylvania, United States, 19610 Canada, Quebec Warner Chilcott Research Facility Montreal, Quebec, Canada, H2X 1P1 Less <<
NCT00541658 Postmenopausal Osteoporosis Phase 3 Completed - -
NCT00717145 Postmenopausal ... More >> Non-lactating Surgically Sterile Less << Phase 1 Completed - United States, Florida ... More >> Research Site Gainesville, Florida, United States Research site Miramar, Florida, United States United States, Texas Research Site Austin, Texas, United States Less <<
NCT00343252 Osteoporosis, Postmenopausal ... More >> Back Pain Spinal Fracture Less << Phase 3 Completed - -
NCT00345644 Osteoporosis Phase 3 Completed - France ... More >> Sanofi-Aventis Paris, France Less <<
NCT00343252 - Completed - -
NCT00846196 Osteoporosis Phase 1 Completed - United States, California ... More >> Research Site San Diego, California, United States, 92123 United States, Florida Research Site Fort Myers, Florida, United States, 33901 Research Site Miramar, Florida, United States, 33025 United States, Nebraska Research Site Omaha, Nebraska, United States, 68154 United States, Texas Research site Austin, Texas, United States, 78752 Research Site Dallas, Texas, United States, 75247 Less <<
NCT00549068 Osteoporosis, Postmenopausal Phase 4 Completed - -
NCT00377234 - Completed - -
NCT01215890 Crohn's Disease ... More >> Low Bone Mineral Density Less << Phase 4 Completed - Canada, Alberta ... More >> Gastrointestinal and Liver Disease Research (GILDR) Group Edmonton, Alberta, Canada, T6G-2X8 Less <<
NCT02063854 Involutional Osteoporosis Phase 2 Phase 3 Completed - Japan ... More >> Nagoya-shi, Aichi, Japan Chiba-shi, Chiba, Japan Narashino-shi, Chiba, Japan Fukuoka-shi, Fukuoka, Japan Kitakyushu-shi, Fukuoka, Japan Onga-gun, Fukuoka, Japan Ebetsu-shi, Hokkaido, Japan Sapporo-shi, Hokkaido, Japan Kako-gun, Hyogo, Japan Morioka-shi, Iwate, Japan Atsugi-shi, Kanagawa, Japan Kawasaki-shi, Kanagawa, Japan Yokohama-shi, Kanagawa, Japan Zushi-shi, Kanagawa, Japan Kumamoto-shi, Kumamoto, Japan Tamana-shi, Kumamoto, Japan Sendai-shi, Miyagi, Japan Tagajo-shi, Miyagi, Japan Miyazaki-shi, Miyazaki, Japan Saito-shi, Miyazaki, Japan Higashi Osaka-shi, Osaka, Japan Saitama-shi, Saitama, Japan Daito-ku, Tokyo, Japan Setagaya-ku, Tokyo, Japan Wakayama-shi, Wakayama, Japan Less <<
NCT02063854 - Completed - -
NCT00216060 Metastatic Prostate Cancer Phase 3 Terminated(Terminated due to l... More >>ow accrual) Less << - -
NCT02106442 - Completed - Japan ... More >> Osaka, Japan Tokyo, Japan Less <<
NCT00594334 Periodontal Disease Phase 4 Unknown January 2011 United States, Ohio ... More >> Uhcmc Recruiting Cleveland, Ohio, United States, 44124 Principal Investigator: james liu, md Less <<
NCT00216060 - Terminated(Terminated due to l... More >>ow accrual) Less << - -
NCT02744482 Prosthesis Loosening Phase 3 Terminated(lack of patients) - France ... More >> CHU Limoges Limoges, France, 87100 Less <<
NCT00405392 Osteoporosis, Postmenopausal Phase 4 Completed - -
NCT00541658 - Completed - -
NCT00405392 - Completed - -
NCT00790101 Osteoporosis, Postmenopausal Phase 4 Terminated - United States, New Jersey ... More >> Sanofi-Aventis Bridgewater, New Jersey, United States, 08807 Less <<
NCT00619957 Other Osteoporosis Phase 3 Completed - -
NCT00577837 Postmenopausal Phase 2 Completed - United States, Florida ... More >> Research Site Daytona Beach, Florida, United States Research Site Gainesville, Florida, United States United States, Kansas Research Site Shawnee Mission, Kansas, United States United States, Texas Research Site San Antonio, Texas, United States Canada, Ontario Research Site Hamilton, Ontario, Canada Canada, Quebec Research Facility Montreal, Quebec, Canada Research Facility Sainte-Foy, Quebec, Canada Croatia Research Facility Zagreb, Croatia Netherlands Research Facility Amsterdam, Netherlands Research Facility Leiden, Netherlands Poland Research Facility Bialystok, Poland Research Site Lublin, Poland Research Site Warszawa, Poland Research Site Wroclaw, Poland Less <<
NCT00755872 Bioavailability Phase 1 Completed - United States, Florida ... More >> Research Site Ft Myers, Florida, United States Research Site Miramar, Florida, United States United States, Texas Research Site Austin, Texas, United States Less <<
NCT00619957 - Completed - -
NCT01675297 Osteoporosis Phase 4 Unknown March 2014 Korea, Republic of ... More >> Chung-ang university hospital Recruiting Seoul, Korea, Republic of, 156-755 Contact: Ah Rong Choi, CRC    8210-2036-4353    baby123@naver.com    Contact: Nahyun Kang, CRA    822-3489-6298    nahyun.kang@hanlim.com    Principal Investigator: Hyoung-Moo Park, MD Less <<
NCT00106028 Osteogenesis Imperfecta Phase 3 Completed - -
NCT01611571 Osteoporosis Phase 3 Completed - United States, New York ... More >> Columbia University Medical Center, Harkness Pavilion New York City, New York, United States, 10032 Less <<
NCT01611571 - Completed - -
NCT00106028 - Completed - -
NCT02089997 - Completed - -
NCT00577850 Osteopenia Os... More >>teoporosis Less << Phase 1 Completed - United States, Florida ... More >> Research Facility Gainesville, Florida, United States United States, Louisiana Research Site New Orleans, Louisiana, United States Less <<
NCT00130403 Osteoporosis, Postmenopausal Phase 4 Completed - United States, New Jersey ... More >> sanofi-aventis, US Bridgewater, New Jersey, United States, 08807 Australia, New South Wales sanofi-aventis, Australia Cove, New South Wales, Australia Belgium sanofi-aventis, Belgium Diegem, Belgium Canada, Quebec sanofi-aventis, Canada Laval, Quebec, Canada France sanofi-aventis, France Paris, France Netherlands sanofi-aventis, Netherlands Gouda, Netherlands United Kingdom sanofi-aventi, UK Guildford, Surrey, United Kingdom Less <<
NCT00919711 - Completed - -
NCT00919711 Osteoporosis Phase 3 Completed - -
NCT02089997 - Completed - Japan ... More >> Osaka, Japan Tokyo, Japan Less <<
NCT00460733 Colles' Fracture Phase 4 Completed - Brazil ... More >> Sanofi-Aventis Administrative Office Sao Paulo, Brazil Less <<
NCT02106455 - Completed - Japan ... More >> Osaka, Japan Tokyo, Japan Less <<
NCT00377234 Post Menopausal Osteoporosis Phase 4 Completed - -
NCT00577421 Postmenopausal Osteoporosis Phase 3 Completed - Australia ... More >> Research Site Concord, Australia Italy Research Facility Sienna, Italy Poland Research Facility Warsaw, Poland Spain Research Facility Barcelona, Spain Sweden Research Facility Goteborg, Sweden Less <<
NCT00699777 Osteoporosis Phase 1 Completed - United States, Florida ... More >> Research Site Gainesville, Florida, United States Research Facility Miramar, Florida, United States United States, Texas Research Facility Austin, Texas, United States Research Facility Dallas, Texas, United States Less <<
NCT01249261 Postmenopausal Women With Oste... More >>oporosis Less << Phase 3 Completed - Australia, New South Wales ... More >> Investigational Site Concord, New South Wales, Australia, 2139 Australia, Victoria Investigational Site Parkville, Victoria, Australia, 3052 Belgium Investigational Site De Pintelaan 185, Gent, Belgium, B-9000 Denmark Investigational Site Hvidovre, Denmark, DK-2650 Finland Investigational Site Oulu, Finland, SF-90 100 Italy Investigational Site Siena, Italy, I-53100 Poland Investigational Site Warsaw, Poland, PL-02315 Investigational Site Warszawa, Poland, PL 03-0335 Investigational Site Warszawa, Poland, PL-04-736 Investigational Site Warszawa, Poland, PL00-909 Spain Investigational Site Barcelona, Spain, 08907 Investigational Site Madrid, Spain, 28040 Sweden Investigational Site Goteborg, Sweden, S-411 32 Less <<
NCT00426777 Prostate Cancer Phase 3 Completed - Canada, British Columbia ... More >> Southern Interior Medical Research Corporation Kelowna, British Columbia, Canada, V1Y 2H4 Dr. Cal Andreou Surrey, British Columbia, Canada, V3V 1N1 Canada, New Brunswick Dr. Allan Patrick Fredericton, New Brunswick, Canada, E3B 5B8 Canada, Ontario The Male/Female Health and Research Centre Barrie, Ontario, Canada, L4M 7G1 Dr. Stanley Flax Brampton, Ontario, Canada, L6T 3J1 Brantford Urology Research, Medical Arts Building Brantford, Ontario, Canada, N3R 4N3 G. Kenneth Jansz Medicine Professional Corporation Burlington, Ontario, Canada, L7N 3V2 Urology Research Centre Burlington, Ontario, Canada, L7S 1V2 Guelph Urology Associates Guelph, Ontario, Canada, N1H 5J1 Credit Valley Medical Arts Centre Mississauga, Ontario, Canada, L5M 4N4 Mor Urology Inc., Bayview Business Centre Newmarket, Ontario, Canada, L3X 1W1 The Male and Female Health Centre Oakville, Ontario, Canada, L6H 3P1 Orillia Urology Associates Orillia, Ontario, Canada, L3V 7V1 Urotec Oshawa, Ontario, Canada, L1H 1B9 Dr. Todd Webster Owen Sound, Ontario, Canada, N4K 2J1 Kawartha Urology Associates Peterborough, Ontario, Canada, K9H 1T6 Dr. Allan Abramovitch Scarborough, Ontario, Canada, M1S 4V5 Northern Urology Centre Sudbury, Ontario, Canada, P3E 4T3 The Male Health Centre Toronto, Ontario, Canada, M6A 3B5 Dr. Roger J. Buckley Willowdale, Ontario, Canada, M2K 2W1 Canada, Quebec Urology South Shore Research Greenfield Park, Quebec, Canada, J4V 2H3 Less <<
NCT00247273 - Completed - -
NCT01249261 - Completed - -
NCT00221299 - Completed - -
NCT00221299 Osteoporosis Phase 4 Completed - United States, California ... More >> UC Davis General Medicine Research Clinic Sacramento, California, United States, 95817 Less <<
NCT00859027 Prostate Cancer Phase 4 Completed - United States, Connecticut ... More >> University of Connecticut Health Center Farmington, Connecticut, United States, 06030 Less <<
NCT00247273 Postmenopausal Osteoporosis Phase 3 Completed - -
NCT00549965 Osteoporosis, Postmenopausal Phase 4 Completed - Korea, Republic of ... More >> Sanofi-Aventis Daegu, Korea, Republic of Less <<
NCT00859027 - Completed - -
NCT00616694 Osteoporosis Phase 4 Completed - United States, New Jersey ... More >> Sanofi-Aventis Bridgewater, New Jersey, United States, 08807 Less <<
NCT00453492 Osteoporosis, Postmenopausal Phase 4 Completed - Turkey ... More >> Sanofi-Aventis Istanbul, Turkey Less <<
NCT00837746 - Completed - United States, California ... More >> Maria Greenwald, MD Palm Desert, California, United States, 92260 United States, Colorado Paul Miller, MD Lakewood, Colorado, United States, 80227 United States, Georgia Grattan Woodson, MD Decatur, Georgia, United States, 30033 Christopher Recknor, MD Gainesville, Georgia, United States, 30501 United States, Nebraska Robert Recker, MD Omaha, Nebraska, United States, 68131 United States, Ohio Nelson Watts, MD Cincinnati, Ohio, United States, 45219 United States, Pennsylvania Ronald D Emkey, MD Wyomissing, Pennsylvania, United States, 19610 Canada, Quebec Louis-Georges Ste-Marie, MD Montreal, Quebec, Canada, H2X 1P1 Less <<
NCT00772395 Bone Loss Phase 4 Completed - Sweden ... More >> Orthopaedic department, Danderyd Hospital Stockholm, Sweden, 18288 Less <<
NCT00452439 Leukemia Lymp... More >>homa Less << Phase 3 Completed - United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00632216 Osteoporosis, Postmenopausal Phase 4 Completed - -
NCT02186600 Osteopenia Phase 3 Active, not recruiting June 2019 United States, Nebraska ... More >> University of Nebraska Medical Center Omaha, Nebraska, United States, 68198-4420 Less <<

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

3.28mL

0.66mL

0.33mL

16.39mL

3.28mL

1.64mL

32.78mL

6.56mL

3.28mL

References

 

Historical Records

Categories